Literature DB >> 6286711

Human chorionic gonadotropin binding to human fetal testes as a function of gestational age.

R L Molsberry, B R Carr, C R Mendelson, E R Simpson.   

Abstract

The characteristics of binding of hCG to testicular tissue obtained from human abortuses of 10--24 weeks gestational age were studied. Specific, saturable binding of [125I]hCG was demonstrated using homogenates of human fetal testicular tissue. The equilibrium dissociation constant ranged from 0.4 x 10(-10) M to 5.5 x 10(-10) M, a finding that is indicative of a high affinity receptor. The capacity to bind hCG was low, but varied strikingly with gestational age. The binding capacity for hCG of tissues from abortuses of gestational age less than 15 weeks and greater than 22 weeks was consistently less than 10.0 pg x mg-1 tissue (2.2 fmol x mg-1 tissue). The binding capacity for hCG of tissues from abortuses of gestational age between 15--20 weeks ranged from 2.4--29.8 pg x mg-1 tissue (0.5--6.5 fmol x mg-1 tissue) with the majority of values being greater than 10 pg x mg-1 tissue (2.2 fmol x mg-1 tissue). On the other hand, receptors for hCG in human fetal ovarian tissue were undetectable, irrespective of gestational age. It is concluded that specific high affinity binding sites for hCG are present in human fetal testes and that the binding capacity is maximum between gestational ages of 15--20 weeks. This increase in binding capacity parallels the surge in testosterone production known to occur during the same period of development. These results suggest that the increase in fetal plasma levels of testosterone during this time in gestation is the result of an increase in the sensitivity of the fetal testis to hCG caused by an increase in the number of hCG receptors, and that hCG most likely is responsible for stimulation of fetal testicular steroidogenesis in utero at this time of gestation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286711     DOI: 10.1210/jcem-55-4-791

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Expression of type II chorionic gonadotropin genes supports a role in the male reproductive system.

Authors:  Andrew M Parrott; Ganapathy Sriram; Yijun Liu; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

Review 2.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

3.  Male pseudohermaphroditism secondary to panhypopituitarism.

Authors:  D P Burgner; S Kinmond; A M Wallace; D G Young; M G Forest; M D Donaldson
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

4.  The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes.

Authors:  Miguel J Gallego; Prashob Porayette; Maria M Kaltcheva; Richard L Bowen; Sivan Vadakkadath Meethal; Craig S Atwood
Journal:  Stem Cell Res Ther       Date:  2010-09-13       Impact factor: 6.832

5.  Placental Weight and Risk of Cryptorchidism and Hypospadias in the Collaborative Perinatal Project.

Authors:  Armen A Ghazarian; Britton Trabert; Barry I Graubard; Matthew P Longnecker; Mark A Klebanoff; Katherine A McGlynn
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

Review 6.  GPER Signaling in Spermatogenesis and Testicular Tumors.

Authors:  Adele Chimento; Rosa Sirianni; Ivan Casaburi; Vincenzo Pezzi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-03-06       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.